We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.46B
AUM Growth
+$64.9M
Cap. Flow
-$124M
Cap. Flow %
-5.06%
Top 10 Hldgs %
17.7%
Holding
268
New
43
Increased
60
Reduced
119
Closed
29

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$20.5M
2
ECVT icon
Ecovyst
ECVT
+$17.5M
3
CRS icon
Carpenter Technology
CRS
+$15.2M
4
QTWO icon
Q2 Holdings
QTWO
+$14.6M
5
OSIS icon
OSI Systems
OSIS
+$13.6M

Sector Composition

Rank Sector Weight
1 Industrials 19.54%
2 Technology 18.2%
3 Healthcare 17.1%
4 Consumer Discretionary 12.08%
5 Financials 11.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXDX
51
DELISTED
Ignyta, Inc.
RXDX
$19.1M 0.78%
1,546,268
-87,077
-5% -$898K
CUBI icon
52
Customers Bancorp
CUBI
$2.65B
$18.7M 0.76%
573,108
-56,038
-9% -$1.62M
TDOC icon
53
Teladoc Health
TDOC
$1.7B
$18.7M 0.76%
563,312
-2,645
-0.5% -$86.7K
GWRE icon
54
Guidewire Software
GWRE
$12.5B
$18.4M 0.75%
236,702
-59,558
-20% -$4.36M
CRS icon
55
Carpenter Technology
CRS
$27.7B
$18.2M 0.74%
+378,776
New +$15.2M
GTHX
56
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$18.1M 0.74%
728,433
+17,977
+3% +$332K
LITE icon
57
Lumentum
LITE
$57B
$17.9M 0.73%
328,669
-212,119
-39% -$12.3M
CIEN icon
58
Ciena
CIEN
$53B
$17.7M 0.72%
807,834
-299,973
-27% -$7.18M
RETA
59
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$17.7M 0.72%
569,416
+162,990
+40% +$4.9M
ECVT icon
60
Ecovyst
ECVT
$1.41B
$17.5M 0.71%
+1,015,410
New +$17.5M
TTWO icon
61
Take-Two Interactive
TTWO
$43.9B
$17.2M 0.7%
168,217
-191,520
-53% -$17.1M
SHOO icon
62
Steven Madden
SHOO
$3.17B
$17.2M 0.7%
594,866
-450
-0.1% -$12.4K
BURL icon
63
Burlington
BURL
$21.7B
$17.1M 0.7%
179,537
-6,785
-4% -$596K
BOX icon
64
Box
BOX
$4.22B
$16.7M 0.68%
865,810
+273,410
+46% +$5.14M
MATW icon
65
Matthews International
MATW
$857M
$15.9M 0.65%
254,870
-17,499
-6% -$1.09M
QTWO icon
66
Q2 Holdings
QTWO
$3.43B
$15.5M 0.63%
+372,628
New +$14.6M
OSIS icon
67
OSI Systems
OSIS
$3.51B
$15.5M 0.63%
169,650
+166,892
+6,051% +$13.6M
OPB
68
DELISTED
Opus Bank Common Stock
OPB
$15.4M 0.63%
642,671
+32,939
+5% +$763K
NEO icon
69
NeoGenomics
NEO
$1.9B
$15.4M 0.63%
1,381,473
+133,102
+11% +$1.3M
IOSP icon
70
Innospec
IOSP
$2.08B
$15.1M 0.61%
244,956
-12,297
-5% -$737K
TNC icon
71
Tennant Co
TNC
$1.47B
$14.9M 0.61%
225,636
-6,672
-3% -$447K
DOOR
72
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$14.9M 0.61%
215,296
-157,417
-42% -$10.9M
CLF icon
73
Cleveland-Cliffs
CLF
$5.29B
$13.7M 0.56%
1,919,438
+332,017
+21% +$2.48M
FRPT icon
74
Freshpet
FRPT
$2.78B
$13.5M 0.55%
860,124
+183,620
+27% +$2.96M
AIMT
75
DELISTED
Aimmune Therapeutics
AIMT
$13.4M 0.55%
542,035
-16,911
-3% -$365K

Similar funds

Emerald Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, Emerald Advisers held 268 positions worth $2.46B, up 2.7% from $2.39B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $124M in Q3 2017, closing 29 positions and reducing 119 holdings. Its most notable exit was Strategy Inc, an estimated $33.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Emerald Advisers opened a new position in Ecovyst worth $17.5M.

  • Emerald Advisers's largest Q3 2017 buy was Ecovyst: 1,015,410 shares worth $17.5M.
  • Emerald Advisers added most to CATALENT, INC. in Q3 2017, an estimated $20.5M increase.
  • Emerald Advisers's biggest Q3 2017 reduction was Veeva Systems, cutting an estimated $26.1M.
  • Emerald Advisers fully exited Strategy Inc in Q3 2017, selling an estimated $33.2M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.46B portfolio in Q3 2017.
  • Emerald Advisers opened 43 new positions and closed 29 in Q3 2017.
  • Emerald Advisers's portfolio value rose 2.7% quarter-over-quarter to $2.46B.

Based on Emerald Advisers's 13F filing for Q3 2017, filed 30 Oct 2017.